US Stock MarketDetailed Quotes

Aptevo Therapeutics (APVO)

Watchlist
  • 4.885
  • -0.245-4.78%
Close Apr 23 16:00 ET
  • 5.020
  • +0.135+2.76%
Pre 07:37 ET
5.77MMarket Cap-0.06P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aptevo Therapeutics (APVO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
6.95%26.31M
-6.05%6M
45.98%7.61M
3.35%6.23M
-7.20%6.48M
-14.81%24.6M
-0.03%6.38M
-20.55%5.21M
-26.34%6.02M
-9.97%6.98M
Selling and administrative expenses
15.14%11.77M
-1.64%2.46M
69.00%3.57M
21.71%2.9M
-11.88%2.85M
-13.14%10.22M
-10.42%2.5M
-21.09%2.11M
-12.33%2.38M
-9.95%3.23M
-General and administrative expense
15.14%11.77M
-1.64%2.46M
69.00%3.57M
21.71%2.9M
-11.88%2.85M
-13.14%10.22M
-10.42%2.5M
-21.09%2.11M
-12.33%2.38M
-9.95%3.23M
Research and development costs
1.13%14.54M
-8.89%3.54M
30.33%4.04M
-8.65%3.33M
-3.17%3.63M
-15.95%14.38M
8.05%3.88M
-20.17%3.1M
-33.30%3.64M
-9.98%3.75M
Operating profit
-6.95%-26.31M
6.05%-6M
-45.98%-7.61M
-3.35%-6.23M
7.20%-6.48M
14.81%-24.6M
0.03%-6.38M
20.55%-5.21M
26.34%-6.02M
9.97%-6.98M
Net non-operating interest income expense
Other net income (expense)
-26.91%345K
171.43%190K
-45.54%61K
-84.40%22K
-51.68%72K
-95.39%472K
-62.77%70K
-50.66%112K
-38.70%141K
-98.45%149K
Special income (charges)
----
----
----
----
----
--0
--0
--0
--0
--0
-Gain on sale of property,plant,equipment
----
----
----
----
----
--0
--0
--0
--0
--0
Other non- operating income (expenses)
-26.91%345K
171.43%190K
-45.54%61K
-84.40%22K
-51.68%72K
-18.34%472K
-62.77%70K
-50.66%112K
-38.70%141K
322.39%149K
Income before tax
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-29.38%-24.13M
-1.87%-6.31M
19.47%-5.1M
25.98%-5.88M
-474.06%-6.83M
Income tax
Net income
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
Net income continuous Operations
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-29.38%-24.13M
-1.87%-6.31M
19.47%-5.1M
25.98%-5.88M
-474.06%-6.83M
Net income discontinuous operations
----
----
----
----
----
--0
--0
--0
--0
--0
Minority interest income
Net income attributable to the parent company
-7.61%-25.97M
8.02%-5.81M
-47.99%-7.55M
-5.46%-6.2M
6.23%-6.41M
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
Preferred stock dividends
Other preferred stock dividends
1.57M
92K
1.48M
0
0
0
Net income attributable to common stockholders
-14.12%-27.54M
6.56%-5.9M
-76.98%-9.03M
-5.46%-6.2M
6.23%-6.41M
-38.59%-24.13M
-6.93%-6.31M
19.47%-5.1M
25.98%-5.88M
-346.45%-6.83M
Basic earnings per share
98.53%-87.27
99.62%-5.9108
98.99%-40.14
99.21%-151.2
98.84%-1.58K
98.87%-5.96K
99.13%-1.56K
98.49%-3.99K
97.10%-19.23K
-159.15%-136.68K
Diluted earnings per share
99.72%-87.27
99.62%-5.9108
98.99%-40.14
99.32%-151.2
98.84%-1.58K
94.04%-31.46K
99.13%-1.56K
98.49%-3.99K
96.64%-22.27K
-159.15%-136.68K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 6.95%26.31M-6.05%6M45.98%7.61M3.35%6.23M-7.20%6.48M-14.81%24.6M-0.03%6.38M-20.55%5.21M-26.34%6.02M-9.97%6.98M
Selling and administrative expenses 15.14%11.77M-1.64%2.46M69.00%3.57M21.71%2.9M-11.88%2.85M-13.14%10.22M-10.42%2.5M-21.09%2.11M-12.33%2.38M-9.95%3.23M
-General and administrative expense 15.14%11.77M-1.64%2.46M69.00%3.57M21.71%2.9M-11.88%2.85M-13.14%10.22M-10.42%2.5M-21.09%2.11M-12.33%2.38M-9.95%3.23M
Research and development costs 1.13%14.54M-8.89%3.54M30.33%4.04M-8.65%3.33M-3.17%3.63M-15.95%14.38M8.05%3.88M-20.17%3.1M-33.30%3.64M-9.98%3.75M
Operating profit -6.95%-26.31M6.05%-6M-45.98%-7.61M-3.35%-6.23M7.20%-6.48M14.81%-24.6M0.03%-6.38M20.55%-5.21M26.34%-6.02M9.97%-6.98M
Net non-operating interest income expense
Other net income (expense) -26.91%345K171.43%190K-45.54%61K-84.40%22K-51.68%72K-95.39%472K-62.77%70K-50.66%112K-38.70%141K-98.45%149K
Special income (charges) ----------------------0--0--0--0--0
-Gain on sale of property,plant,equipment ----------------------0--0--0--0--0
Other non- operating income (expenses) -26.91%345K171.43%190K-45.54%61K-84.40%22K-51.68%72K-18.34%472K-62.77%70K-50.66%112K-38.70%141K322.39%149K
Income before tax -7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-29.38%-24.13M-1.87%-6.31M19.47%-5.1M25.98%-5.88M-474.06%-6.83M
Income tax
Net income -7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M-346.45%-6.83M
Net income continuous Operations -7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-29.38%-24.13M-1.87%-6.31M19.47%-5.1M25.98%-5.88M-474.06%-6.83M
Net income discontinuous operations ----------------------0--0--0--0--0
Minority interest income
Net income attributable to the parent company -7.61%-25.97M8.02%-5.81M-47.99%-7.55M-5.46%-6.2M6.23%-6.41M-38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M-346.45%-6.83M
Preferred stock dividends
Other preferred stock dividends 1.57M92K1.48M000
Net income attributable to common stockholders -14.12%-27.54M6.56%-5.9M-76.98%-9.03M-5.46%-6.2M6.23%-6.41M-38.59%-24.13M-6.93%-6.31M19.47%-5.1M25.98%-5.88M-346.45%-6.83M
Basic earnings per share 98.53%-87.2799.62%-5.910898.99%-40.1499.21%-151.298.84%-1.58K98.87%-5.96K99.13%-1.56K98.49%-3.99K97.10%-19.23K-159.15%-136.68K
Diluted earnings per share 99.72%-87.2799.62%-5.910898.99%-40.1499.32%-151.298.84%-1.58K94.04%-31.46K99.13%-1.56K98.49%-3.99K96.64%-22.27K-159.15%-136.68K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +18.81%
Sample Name
Sample Code
 +16.13%
Sample Name
Sample Code
 +12.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+11.25%
5
United Sts Brent Oil Fd Lp Unit
BNO
+8.06%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +13.80%
Sample Name
Sample Code
 +12.99%
Sample Name
Sample Code
 +8.01%
4
Chagee Holdings
CHA
+5.92%
5
Taiwan Semiconductor
TSM
+5.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At midnight Beijing time on April 24, Iranian Parliament Speaker Kalibaf announced his withdrawal from the Iran-US negotiation delegation. M Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -